FY26 non-GAAP adjusted EBITDA expected to be $95 million to $98 million.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OFIX:
- Orthofix price target lowered to $18 from $22 at Stifel
- Orthofix International Maps Steady Growth After Earnings
- Orthofix price target lowered to $20 from $24 at Canaccord
- Orthofix Medical: Strengthening Growth Momentum and Profitability Supports Compelling Buy-Rated Valuation
- Orthofix price target lowered to $17 from $18 at Barrington